Reverb Therapeutics

Vancouver, Canada · Founded 2023 · Privately Held (backing)

Developer of a cytokine therapy designed for cancer treatment and promoting targeted immune activation while limiting toxicity. Reverb Therapeutics is based in Vancouver, Canada and was founded in 2023. It has raised $12.5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$12.5M
Last round
—

Who backs Reverb Therapeutics?

8 investors
InvestorType
Life Sciences BCOther
InBC InvestmentAsset manager
Finchley Healthcare VenturesOther
Amplitude Ventures—
InBC Investment Corp. (InBC)—
KdT Ventures—
Myeloma Investment Fund—
Seido Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Reverb Therapeutics investors

8 investors are on record for Reverb Therapeutics, including Life Sciences BC, InBC Investment, Finchley Healthcare Ventures and Amplitude Ventures.

Free account
More of Reverb Therapeutics with a free account
  • ·Watch Reverb Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Reverb Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View